Study Notes on Multiple IV Bolus and Infusion Dosing

Results and Guidance on IV Bolus and Infusion Dosing

  • Exam Results

    • If results are not satisfactory, there are additional opportunities.
    • Students who did underperform should have received communication from Dr. Wu.
    • Encourage students to schedule meetings with assigned TAs next week.
    • Importance of submitting a reflection form by the following Friday.

  • Support Resources

    • Emphasis on the availability of support for students facing challenges.
    • Examination review sessions organized one-on-one.
    • Focus on identifying specific difficulties and resolving them collaboratively.

Introduction to Multiple IV Bolus and Infusion

  • Definitions

    • Multiple IV bolus: Administration of multiple doses of a drug after specified intervals (dosing regimen).
    • Tau (τ): The time interval after each dose administration.
    • Goal: Maintain drug concentration within therapeutic window.

  • Therapeutic Concentration

    • Single dose might decrease below therapeutic range over time.
    • Critical for chronic diseases to maintain concentration within the therapeutic window.

  • Dosing Intervals

    • Tailored for each medication based on half-life and patient-specific parameters.

Steady State Goals and Pharmacokinetics

  • Steady State Definition

    • Achieved when the rate of drug input equals the rate of elimination.

  • Principle of Superposition

    • Total drug in the body during multiple dosing = new dose + residual drug from previous doses.
    • Example shows four doses administered at intervals resulting in varying concentrations over time.

  • Steady State Dynamics

    • Continuous dosing leads to fluctuations but stabilizes at steady state.
    • At steady state, concentration remains within the therapeutic range despite multiple dosing.

Equations for Multiple IV Bolus and Infusion

  • Multiple IV Bolus Equation

    • $CP = \frac{dose}{V}$ where $CP$ is plasma concentration, $V$ is volume of distribution.
    • Decay function: $e^{-K_{el} t}$.
    • Use single dose equation enhanced with an accumulation factor.
    • Accumulation factor: $e^{-n K_{el} \tau}$; $n$ = number of doses.

  • Dosing Interval Variables

    • Distinction between tau (dose interval) and total therapy time (t).
    • Example calculations demonstrate how to determine concentration at specified times post-dosing.

  • Fluctuation Calculation

    • Fluctuation should remain within predetermined maximum and minimum effective concentrations.
    • Formula: $\frac{C{P,\text{max}}}{C{P,\text{min}}} = e^{-K_{el} \tau}$.

Time to Steady State

  • General Rule: Steady state typically achieved after 4-5 half-lives.
    • This is independent of dosing variability (tau) or other patient factors.

Impact of Clearance and Volume Changes

  • Impact of Clearance on Pharmacokinetics

    • Increased clearance ($K_{el}$) results in steeper slope on clearance graph.
    • Reduced clearance leads to a slower elimination rate and lengthened half-life.
    • Faster clearance corresponds to quicker steady state achievement.

  • Volume of Distribution Effects

    • Increased volume results in decreased elimination rate; inverse relationship.
    • Changes in volume impact steady state concentrations: smaller volumes lead to higher peak concentrations.
    • Effect on pharmacological profiles governed by these relationships.

Dosing Interval Determination

  • To calculate $ au$, use: τ=ln⁡(C<em>P,maxsteady stateC</em>P,minsteady state)÷Kel\tau = \ln \left( \frac{C<em>{P,\text{max}}^{\text{steady state}}}{C</em>{P,\text{min}}^{\text{steady state}}} \right) \div K_{el}
    • Rounding considerations depending on clinical limits.

Loading and Maintenance Doses

  • Loading Dose Calculation

    • Formula: $Loading Dose = C_{Pmax}^{\text{desired}} \times V$.
    • Ensures rapid achievement of therapeutic concentration.

  • Maintenance Dose Calculation

    • Maintenance: similar to loading but accounts for accumulation factor:
      MaintenanceDose=C<em>Pmaxsteady state×V1−e−K</em>elτMaintenance Dose = \frac{C<em>{Pmax}^{\text{steady state}} \times V}{1 - e^{-K</em>{el} \tau}}

Transition to IV Infusion

  • Overview of IV Infusion

    • Drug delivered continuously over time (e.g., 100 mg over 30 minutes).
    • Infusion rate represented by $K_0$.

  • Infusion Profile Dynamics

    • Concentration increases gradually to peak and then declines after stopping infusion.
    • Requires understanding of decay functions related to single and multiple doses during and post-infusion.

  • CP Equation During Infusion

    • Steady state can be expressed as:
      C<em>Pss=K</em>0CL×accumulationfactorC<em>{P}^{\text{ss}} = \frac{K</em>0}{CL}\times accumulation factor.

Clinical Sampling and Timing Considerations

  • Proper Timing for Blood Samples
    • Blood samples should not be drawn immediately post-infusion to avoid inaccurate readings.
    • Different sampling protocols exist for assessing peak or trough concentrations.
    • Steady state sampling occurs after 3-4 half-lives.

Summary of IV Bolus vs. Infusion

  • Contrast between therapeutic concentration profiles for multiple IV bolus vs. IV infusion.
    • IV bolus typically exhibits sharp peaks and troughs; IV infusion has a more gradual profile.
    • Importance of distinguishing equations relating to each method for accuracy in clinical application.

Homework Assignments Overview

  • Two key homework problems related to IV bolus dosing and maintaining concentrations within specified thresholds.
    • Emphasis on application of formulas and understanding pharmacokinetic principles to reach solutions.